TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/24 21:50 | 11/15/24 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | TX | D | M.d | 874 | 23.48 | 0 | 37 | 16 | D | ||||||||||||||||
11/15/24 21:50 | 11/15/24 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | TX | D | S.d | -5,440 | 146.11 | 0 | -37 | -70 | 16 | D | |||||||||||||||
5/26/23 21:05 | 5/25/23 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | TX | D | M.d | 0 | 0.00 | 0 | 4 | 66 | 9 | D | |||||||||||||||
5/27/22 21:45 | 5/25/22 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | TX | D | M.d | 0 | 0.00 | 0 | 1 | 46 | 4 | D | |||||||||||||||
6/2/21 19:58 | 5/28/21 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | TX | D | M.d | 0 | 0.00 | 0 | 3 | New | 3 | D | |||||||||||||||
8/11/20 18:20 | 8/7/20 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | CA | D | M.d | 32 | 24.42 | 0 | 1 | 0 | D | ||||||||||||||||
8/11/20 18:20 | 8/7/20 | NTRA | Natera, Inc. | DE | Health | Health | Medical Laboratories | Baynes Roy D. | CA | D | S.d | -70 | 53.47 | 0 | -1 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |